Walk-ins Welcome
Walk-ins Welcome
INSURANCE PARTNERS
Our first class, on site billing team is readily available for patient or clinician questions.
Provider networks allow health plans to select providers that meet certain standards to be a part of their networks. This helps to ensure that consumers have access to high quality and effective care. PCG Molecular has successfully partnered as an in-network provider with the extensive list of health plan networks.
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care




COVID-19 Testing and Vaccinations

Mon-Fri 9am-6pm
Sat-Sun 10am-4pm
Mon-Fri 10am-4pm

news
CDC Recommends Moderna Booster at 5 Months
CDC is adjusting our recommendation for when people can receive a booster shot, shortening the interval from 6 months to 5 months. Earlier this week CDC made this recommendation for recipients of a Pfizer-BioNTech primary series and we’re extending this recommendation to recipients of a Moderna primary series. This means that people who initially received an mRNA vaccine series – two doses of Moderna or Pfizer-BioNTech – can now receive an mRNA booster shot 5 months after completing their initial series.
CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds
Today, CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
Data show that COVID-19 boosters help broaden and strengthen protection against Omicron and other SARS-CoV-2 variants. ACIP reviewed the available safety data following the administration of over 25 million vaccine doses in adolescents; COVID-19 vaccines are safe and effective.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-17.